Op2lysis

Provider of drugs for treating neurology diseases

placeBoulogne Billancourt, Ile De France, France calendar_todayFounded 2016 groups9 employees language op2lysis.com

Innovation

1 patent family — focus: Chemistry & metallurgy, Human necessities; filing pace slowing. Cited 30 times.

YearFilings
20211
20221
20231

Investor mix

5 investors on record.

Investor typeCountShare
Venture capital120%
Accelerator & incubator360%
Other / undisclosed120%
Coming soon